| Identification | Back Directory | [Name]
BMS-566419 | [CAS]
566161-24-8 | [Synonyms]
BMS-566419
N-[1-[6-(4-Ethyl-1-piperazinyl)-3-pyridinyl]-1-methylethyl]-2-fluoro-9,10-dihydro-9-oxo-3-acridinecarboxamide | [Molecular Formula]
C28H30FN5O2 | [MOL File]
566161-24-8.mol | [Molecular Weight]
487.57 |
| Chemical Properties | Back Directory | [Boiling point ]
664.7±55.0 °C(Predicted) | [density ]
1.244±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
12.20±0.20(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
BMS 566419 is a inosine 5’-monophosphate dehydrogenase (IMPDH) inhibitor, possesses suppressive effect on UUO-induced renal fibrosis in histopathology experiments and decreases collagen content and the expression of collagen type 1 mRNA. | [storage]
Store at -20°C |
|
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|